Concepts (190)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Oxidoreductases Acting on CH-NH Group Donors | 9 | 2014 | 39 | 0.950 |
Why?
|
| Cofilin 1 | 2 | 2014 | 6 | 0.850 |
Why?
|
| Sphingosine N-Acyltransferase | 3 | 2019 | 62 | 0.840 |
Why?
|
| Endoplasmic Reticulum | 2 | 2019 | 148 | 0.750 |
Why?
|
| Ceramides | 6 | 2019 | 578 | 0.700 |
Why?
|
| Mitochondrial Proteins | 2 | 2019 | 113 | 0.690 |
Why?
|
| Folic Acid | 5 | 2014 | 123 | 0.680 |
Why?
|
| Aldehyde Dehydrogenase | 4 | 2014 | 18 | 0.680 |
Why?
|
| Mitochondrial Membranes | 1 | 2019 | 45 | 0.670 |
Why?
|
| Stress, Physiological | 1 | 2019 | 215 | 0.610 |
Why?
|
| Membrane Proteins | 2 | 2019 | 617 | 0.610 |
Why?
|
| Lung Neoplasms | 4 | 2018 | 1173 | 0.600 |
Why?
|
| Mitochondria | 3 | 2019 | 643 | 0.570 |
Why?
|
| Cell Movement | 3 | 2017 | 630 | 0.520 |
Why?
|
| rac1 GTP-Binding Protein | 1 | 2014 | 23 | 0.480 |
Why?
|
| rhoA GTP-Binding Protein | 1 | 2014 | 37 | 0.480 |
Why?
|
| Adenocarcinoma | 2 | 2014 | 475 | 0.400 |
Why?
|
| Protein Transport | 5 | 2019 | 280 | 0.380 |
Why?
|
| Cell Line, Tumor | 10 | 2019 | 1851 | 0.370 |
Why?
|
| Protein Phosphatase 1 | 1 | 2010 | 36 | 0.360 |
Why?
|
| Protein Phosphatase 2 | 1 | 2010 | 67 | 0.360 |
Why?
|
| Phosphorylation | 7 | 2016 | 1200 | 0.320 |
Why?
|
| Apoptosis | 5 | 2018 | 1641 | 0.300 |
Why?
|
| Tumor Suppressor Protein p53 | 2 | 2005 | 231 | 0.280 |
Why?
|
| Drug Resistance, Neoplasm | 2 | 2019 | 332 | 0.260 |
Why?
|
| Cell Membrane | 2 | 2018 | 525 | 0.250 |
Why?
|
| Gene Expression | 2 | 2013 | 770 | 0.240 |
Why?
|
| Signal Transduction | 4 | 2019 | 2689 | 0.230 |
Why?
|
| Cell Nucleus | 3 | 2015 | 305 | 0.220 |
Why?
|
| G1 Phase | 1 | 2003 | 42 | 0.220 |
Why?
|
| Gene Expression Regulation, Neoplastic | 3 | 2019 | 756 | 0.210 |
Why?
|
| Inflammasomes | 1 | 2022 | 39 | 0.210 |
Why?
|
| Ubiquitin-Activating Enzymes | 1 | 2022 | 21 | 0.210 |
Why?
|
| Animals | 14 | 2022 | 20881 | 0.200 |
Why?
|
| Ubiquitin | 1 | 2022 | 74 | 0.200 |
Why?
|
| Antineoplastic Agents | 2 | 2019 | 1070 | 0.180 |
Why?
|
| Mice | 8 | 2022 | 8474 | 0.180 |
Why?
|
| Mice, SCID | 3 | 2017 | 238 | 0.180 |
Why?
|
| Sequence Homology, Amino Acid | 2 | 2011 | 231 | 0.180 |
Why?
|
| Mutation | 3 | 2016 | 1213 | 0.180 |
Why?
|
| Mice, Knockout | 3 | 2019 | 1692 | 0.180 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 1 | 2003 | 300 | 0.180 |
Why?
|
| Dietary Supplements | 2 | 2014 | 332 | 0.170 |
Why?
|
| CRISPR-Cas Systems | 1 | 2019 | 41 | 0.170 |
Why?
|
| Melanoma | 1 | 2022 | 335 | 0.160 |
Why?
|
| Glutamine | 1 | 2019 | 45 | 0.160 |
Why?
|
| Molecular Docking Simulation | 2 | 2018 | 78 | 0.160 |
Why?
|
| Molecular Motor Proteins | 1 | 2018 | 14 | 0.160 |
Why?
|
| Myosin Heavy Chains | 1 | 2018 | 49 | 0.160 |
Why?
|
| Receptor-Interacting Protein Serine-Threonine Kinases | 1 | 2018 | 30 | 0.160 |
Why?
|
| Humans | 21 | 2022 | 68618 | 0.160 |
Why?
|
| Lipid Metabolism | 1 | 2019 | 186 | 0.160 |
Why?
|
| RNA, Small Interfering | 3 | 2016 | 434 | 0.160 |
Why?
|
| Neoplasm Transplantation | 2 | 2017 | 160 | 0.150 |
Why?
|
| Esophageal Neoplasms | 1 | 2019 | 150 | 0.150 |
Why?
|
| Necrosis | 1 | 2018 | 239 | 0.150 |
Why?
|
| Papillomavirus E7 Proteins | 1 | 2017 | 13 | 0.150 |
Why?
|
| Receptors, Transforming Growth Factor beta | 1 | 2017 | 56 | 0.150 |
Why?
|
| Cilia | 1 | 2017 | 94 | 0.140 |
Why?
|
| fms-Like Tyrosine Kinase 3 | 1 | 2016 | 21 | 0.140 |
Why?
|
| Neoplasm Metastasis | 1 | 2017 | 306 | 0.140 |
Why?
|
| Cisplatin | 1 | 2017 | 192 | 0.140 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2019 | 331 | 0.140 |
Why?
|
| Hypoglycemic Agents | 1 | 2019 | 362 | 0.130 |
Why?
|
| Gene Expression Regulation, Enzymologic | 2 | 2010 | 282 | 0.130 |
Why?
|
| Piperidines | 1 | 2016 | 123 | 0.130 |
Why?
|
| Benzimidazoles | 1 | 2016 | 128 | 0.130 |
Why?
|
| Leukemia, Myeloid, Acute | 1 | 2016 | 116 | 0.130 |
Why?
|
| Carcinoma, Lewis Lung | 1 | 2015 | 20 | 0.130 |
Why?
|
| Telomerase | 1 | 2015 | 85 | 0.120 |
Why?
|
| BH3 Interacting Domain Death Agonist Protein | 1 | 2014 | 22 | 0.120 |
Why?
|
| p21-Activated Kinases | 1 | 2014 | 14 | 0.120 |
Why?
|
| Mitogen-Activated Protein Kinase 9 | 1 | 2014 | 11 | 0.120 |
Why?
|
| Mitogen-Activated Protein Kinase 8 | 1 | 2014 | 17 | 0.120 |
Why?
|
| Methylation | 1 | 2014 | 56 | 0.120 |
Why?
|
| cdc42 GTP-Binding Protein | 1 | 2014 | 20 | 0.120 |
Why?
|
| Protein Interaction Domains and Motifs | 1 | 2014 | 57 | 0.120 |
Why?
|
| Cytosol | 3 | 2010 | 123 | 0.120 |
Why?
|
| Lysophospholipids | 1 | 2015 | 209 | 0.110 |
Why?
|
| Glycine N-Methyltransferase | 1 | 2013 | 1 | 0.110 |
Why?
|
| Lymphatic Metastasis | 1 | 2014 | 274 | 0.110 |
Why?
|
| Administration, Oral | 1 | 2014 | 411 | 0.110 |
Why?
|
| Epithelial-Mesenchymal Transition | 1 | 2014 | 135 | 0.110 |
Why?
|
| Sphingosine | 1 | 2015 | 315 | 0.110 |
Why?
|
| Mice, Inbred C57BL | 1 | 2019 | 2791 | 0.110 |
Why?
|
| Neoplasm Proteins | 1 | 2015 | 307 | 0.110 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2014 | 284 | 0.100 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2013 | 194 | 0.100 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 2017 | 629 | 0.100 |
Why?
|
| Cell Survival | 1 | 2014 | 901 | 0.100 |
Why?
|
| Catalysis | 3 | 2022 | 123 | 0.100 |
Why?
|
| Stress Fibers | 1 | 2010 | 10 | 0.090 |
Why?
|
| Folic Acid Deficiency | 1 | 2010 | 16 | 0.090 |
Why?
|
| Evolution, Molecular | 1 | 2011 | 79 | 0.090 |
Why?
|
| Prostatic Neoplasms | 2 | 2014 | 778 | 0.090 |
Why?
|
| Acyl Carrier Protein | 1 | 2009 | 1 | 0.090 |
Why?
|
| Transferases (Other Substituted Phosphate Groups) | 1 | 2009 | 15 | 0.090 |
Why?
|
| Phylogeny | 1 | 2011 | 197 | 0.090 |
Why?
|
| Serine | 2 | 2009 | 99 | 0.090 |
Why?
|
| Actins | 1 | 2010 | 249 | 0.080 |
Why?
|
| Neoplasm Invasiveness | 1 | 2010 | 369 | 0.080 |
Why?
|
| Genes, p53 | 1 | 2009 | 41 | 0.080 |
Why?
|
| Cell Line | 4 | 2018 | 1752 | 0.080 |
Why?
|
| RNA Interference | 2 | 2009 | 266 | 0.080 |
Why?
|
| JNK Mitogen-Activated Protein Kinases | 1 | 2009 | 140 | 0.080 |
Why?
|
| A549 Cells | 2 | 2018 | 50 | 0.080 |
Why?
|
| Genetic Variation | 1 | 2009 | 220 | 0.080 |
Why?
|
| Enzyme Inhibitors | 1 | 2010 | 659 | 0.070 |
Why?
|
| Neoplasms | 1 | 2018 | 1667 | 0.070 |
Why?
|
| Tetrahydrofolate Dehydrogenase | 1 | 2006 | 9 | 0.070 |
Why?
|
| Leucovorin | 1 | 2006 | 35 | 0.070 |
Why?
|
| Guanosine Triphosphate | 1 | 2005 | 65 | 0.070 |
Why?
|
| Transfection | 2 | 2009 | 782 | 0.070 |
Why?
|
| Apoptosis Regulatory Proteins | 1 | 2005 | 100 | 0.060 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 2005 | 204 | 0.060 |
Why?
|
| Adenosine Triphosphate | 1 | 2005 | 314 | 0.060 |
Why?
|
| Up-Regulation | 1 | 2006 | 682 | 0.060 |
Why?
|
| Male | 6 | 2019 | 37321 | 0.050 |
Why?
|
| Cell Death | 2 | 2017 | 329 | 0.050 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 1 | 2003 | 78 | 0.050 |
Why?
|
| Ubiquitins | 1 | 2022 | 22 | 0.050 |
Why?
|
| Catalytic Domain | 1 | 2022 | 99 | 0.050 |
Why?
|
| Protein Binding | 2 | 2015 | 1027 | 0.050 |
Why?
|
| Cell Proliferation | 2 | 2017 | 1174 | 0.050 |
Why?
|
| Cell Cycle | 2 | 2013 | 312 | 0.040 |
Why?
|
| Disease Models, Animal | 2 | 2017 | 2550 | 0.040 |
Why?
|
| Enzyme Activation | 2 | 2013 | 791 | 0.040 |
Why?
|
| Cloning, Molecular | 2 | 2010 | 357 | 0.040 |
Why?
|
| Phenformin | 1 | 2019 | 3 | 0.040 |
Why?
|
| Glutaminase | 1 | 2019 | 7 | 0.040 |
Why?
|
| Thiadiazoles | 1 | 2019 | 7 | 0.040 |
Why?
|
| Benzeneacetamides | 1 | 2019 | 11 | 0.040 |
Why?
|
| F-Box Proteins | 1 | 2019 | 14 | 0.040 |
Why?
|
| Cyclin D1 | 1 | 2019 | 37 | 0.040 |
Why?
|
| Mechanistic Target of Rapamycin Complex 1 | 1 | 2019 | 32 | 0.040 |
Why?
|
| Cyclin-Dependent Kinase 6 | 1 | 2019 | 28 | 0.040 |
Why?
|
| Cyclin-Dependent Kinase 4 | 1 | 2019 | 36 | 0.040 |
Why?
|
| Oogenesis | 1 | 2018 | 10 | 0.040 |
Why?
|
| Substrate Specificity | 2 | 2009 | 234 | 0.040 |
Why?
|
| Retinoblastoma Protein | 1 | 2019 | 75 | 0.040 |
Why?
|
| Metformin | 1 | 2019 | 63 | 0.040 |
Why?
|
| Drug Synergism | 1 | 2019 | 260 | 0.040 |
Why?
|
| Kidney | 1 | 2003 | 945 | 0.040 |
Why?
|
| Ovary | 1 | 2018 | 99 | 0.040 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2019 | 304 | 0.040 |
Why?
|
| Molecular Targeted Therapy | 1 | 2019 | 170 | 0.040 |
Why?
|
| Drosophila melanogaster | 1 | 2018 | 80 | 0.040 |
Why?
|
| Smad7 Protein | 1 | 2017 | 11 | 0.040 |
Why?
|
| Biological Transport | 1 | 2018 | 210 | 0.040 |
Why?
|
| Heterografts | 1 | 2017 | 70 | 0.040 |
Why?
|
| Energy Metabolism | 1 | 2019 | 222 | 0.040 |
Why?
|
| Gene Knockdown Techniques | 1 | 2017 | 196 | 0.040 |
Why?
|
| Dynamins | 1 | 2016 | 14 | 0.040 |
Why?
|
| GTP Phosphohydrolases | 1 | 2016 | 46 | 0.030 |
Why?
|
| Base Sequence | 2 | 2009 | 1015 | 0.030 |
Why?
|
| Mice, Inbred NOD | 1 | 2016 | 138 | 0.030 |
Why?
|
| Cyclic AMP-Dependent Protein Kinases | 1 | 2016 | 93 | 0.030 |
Why?
|
| Microtubule-Associated Proteins | 1 | 2016 | 114 | 0.030 |
Why?
|
| Allosteric Regulation | 1 | 2015 | 58 | 0.030 |
Why?
|
| Caspase 8 | 1 | 2014 | 40 | 0.030 |
Why?
|
| Threonine | 1 | 2014 | 47 | 0.030 |
Why?
|
| Amino Acid Motifs | 1 | 2014 | 77 | 0.030 |
Why?
|
| Molecular Conformation | 1 | 2013 | 128 | 0.030 |
Why?
|
| DNA Damage | 1 | 2013 | 190 | 0.030 |
Why?
|
| Recombinant Proteins | 1 | 2013 | 742 | 0.020 |
Why?
|
| Models, Molecular | 1 | 2013 | 546 | 0.020 |
Why?
|
| Invertebrates | 1 | 2011 | 8 | 0.020 |
Why?
|
| Receptors, Androgen | 1 | 1991 | 34 | 0.020 |
Why?
|
| Exons | 1 | 2011 | 122 | 0.020 |
Why?
|
| Aldehyde Dehydrogenase, Mitochondrial | 1 | 2010 | 21 | 0.020 |
Why?
|
| COS Cells | 1 | 2010 | 155 | 0.020 |
Why?
|
| Pantetheine | 1 | 2009 | 1 | 0.020 |
Why?
|
| Sequence Alignment | 1 | 2010 | 165 | 0.020 |
Why?
|
| Biocatalysis | 1 | 2009 | 23 | 0.020 |
Why?
|
| Genomics | 1 | 2011 | 168 | 0.020 |
Why?
|
| Gene Silencing | 1 | 2009 | 137 | 0.020 |
Why?
|
| RNA, Neoplasm | 1 | 2009 | 76 | 0.020 |
Why?
|
| Swine | 1 | 2010 | 672 | 0.020 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 1 | 2009 | 134 | 0.020 |
Why?
|
| Amino Acid Sequence | 1 | 2010 | 1083 | 0.020 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 1 | 2009 | 175 | 0.020 |
Why?
|
| Molecular Sequence Data | 1 | 2010 | 1447 | 0.020 |
Why?
|
| DNA Primers | 1 | 2006 | 302 | 0.020 |
Why?
|
| Liver | 1 | 1991 | 1118 | 0.020 |
Why?
|
| Treatment Outcome | 1 | 2017 | 7029 | 0.020 |
Why?
|
| Drug Resistance | 1 | 2006 | 223 | 0.020 |
Why?
|
| Rats | 2 | 2010 | 5300 | 0.020 |
Why?
|
| Female | 2 | 2018 | 38074 | 0.010 |
Why?
|
| Metribolone | 1 | 1991 | 2 | 0.010 |
Why?
|
| Receptors, Estrogen | 1 | 1991 | 142 | 0.010 |
Why?
|